Predictive value of serum HER2 ECD in patients with HER2-positive advanced gastric cancer treated with trastuzumab plus chemotherapy
Crossref DOI link: https://doi.org/10.1007/s00535-015-1046-3
Published Online: 2015-02-22
Published Print: 2015-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Zhou, Jun
Peng, Zhi
Liu, Yi
Gong, Jifang
Zhang, Xiaotian
Lu, Ming
Gao, Jing
Li, Yili
Li, Yanyan
Shen, Lin
Text and Data Mining valid from 2015-02-22